标题
Trial Watch
作者
关键词
-
出版物
OncoImmunology
Volume 2, Issue 12, Pages e26621
出版商
Informa UK Limited
发表日期
2014-01-26
DOI
10.4161/onci.26621
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma
- (2013) K Yoshimura et al. BRITISH JOURNAL OF CANCER
- Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide
- (2013) Elise P. Salerno et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer
- (2013) Daniela Fenoglio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Destruction of Insulin Receptor Substrates for Cancer Treatment
- (2013) H. Reuveni et al. CANCER RESEARCH
- Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
- (2013) Ryuji Takahashi et al. CANCER SCIENCE
- Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer
- (2013) Hajime Ishikawa et al. Gastric Cancer
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer
- (2013) Guru Sonpavde et al. INVESTIGATIONAL NEW DRUGS
- Selection of Immunostimulant AS15 for Active Immunization With MAGE-A3 Protein: Results of a Randomized Phase II Study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma
- (2013) Wim H.J. Kruit et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy
- (2013) Fernando Ulloa-Montoya et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting of Antigens to B Lymphocytes via CD19 as a Means for Tumor Vaccine Development
- (2013) Y. Ma et al. JOURNAL OF IMMUNOLOGY
- Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
- (2013) Hiroyuki Suzuki et al. Journal of Translational Medicine
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo
- (2013) Jun Zhang et al. PLoS One
- Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells
- (2013) Ashley L. Wilson et al. PLoS One
- Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors
- (2013) F. Sandoval et al. Science Translational Medicine
- Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination
- (2013) Yu Sawada et al. Human Vaccines & Immunotherapeutics
- Immunotherapy of HPV-associated head and neck cancer
- (2013) Mevyn Nizard et al. OncoImmunology
- Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
- (2013) Magalie Dosset et al. OncoImmunology
- Novel multifunctional antibody approved for the treatment of breast cancer
- (2013) Domenico Mavilio et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
- (2013) Valerie Chew et al. OncoImmunology
- The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
- (2013) Aaron S. Mansfield et al. OncoImmunology
- New immunotherapeutic paradigms for castration-resistant prostate cancer
- (2013) Lorenzo Galluzzi OncoImmunology
- Victories and deceptions in tumor immunology
- (2013) Guido Kroemer et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Interferon α may be back on track to treat acute myeloid leukemia
- (2013) Evelien L.J.M. Smits et al. OncoImmunology
- Trial watch
- (2013) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+head and neck cancer cells
- (2013) Chwee Ming Lim et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2013) Laurie Menger et al. OncoImmunology
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
- (2012) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
- (2012) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
- (2012) Mads Hald Andersen CANCER IMMUNOLOGY IMMUNOTHERAPY
- SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
- (2012) Satoshi Kawaguchi et al. CANCER SCIENCE
- Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
- (2012) Hidekazu Kameshima et al. CANCER SCIENCE
- Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors
- (2012) Isamu Okamoto et al. CANCER SCIENCE
- Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor
- (2012) Hidetoshi Hayashi et al. CANCER SCIENCE
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
- (2012) P. Filipazzi et al. CLINICAL CANCER RESEARCH
- Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
- (2012) M. Dosset et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
- (2012) Y. Sawada et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- Vaccination using peptides spanning the SYT–SSX tumor-specific translocation
- (2012) Jordan E Bloom et al. Expert Review of Vaccines
- Cancer vaccines: should we be targeting patients with less aggressive disease?
- (2012) Diane F Hale et al. Expert Review of Vaccines
- Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity
- (2012) Kirstine Lavrsen et al. GLYCOCONJUGATE JOURNAL
- Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide
- (2012) Shingo Eikawa et al. INTERNATIONAL JOURNAL OF CANCER
- Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
- (2012) Eliane C.M. Zeestraten et al. INTERNATIONAL JOURNAL OF CANCER
- WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial
- (2012) Takashi Miyatake et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
- (2012) Erika Hamilton et al. Journal of Translational Medicine
- ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner
- (2012) Huai-Xiang Hao et al. NATURE
- Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors
- (2012) Bon-Kyoung Koo et al. NATURE
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
- (2012) E Lainey et al. ONCOGENE
- Louis Pasteur, the Father of Immunology?
- (2012) Kendall A. Smith Frontiers in Immunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Combining targeted therapy with immunotherapy (interferon-α)
- (2012) Lei L. Chen et al. OncoImmunology
- Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
- (2012) Adriana J. Michielsen et al. OncoImmunology
- Can the exome and the immunome converge on the design of efficient cancer vaccines?
- (2012) Guido Kroemer et al. OncoImmunology
- NY-ESO-1 expression in sarcomas
- (2012) Jin-Ping Lai et al. OncoImmunology
- Trial Watch: Monoclonal antibodies in cancer therapy
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
- (2012) Else-Marit Inderberg-Suso et al. OncoImmunology
- Understanding key assay parameters that affect measurements of trastuzumab-mediated ADCC against Her2 positive breast cancer cells
- (2012) Timothy Kute et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
- (2012) Erika Vacchelli et al. OncoImmunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study
- (2011) A. Kotsakis et al. ANNALS OF ONCOLOGY
- Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination
- (2011) C. Pospori et al. BLOOD
- Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001
- (2011) Eleni-Kyriaki Vetsika et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
- (2011) Robert E. Hunger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
- (2011) Else M. Inderberg Suso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting p53 to mitochondria for cancer therapy
- (2011) Lorenzo Galluzzi et al. CELL CYCLE
- Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
- (2011) Sylvain Thépot et al. CELL CYCLE
- The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation
- (2011) Holger Hackstein et al. CELLULAR IMMUNOLOGY
- Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
- (2011) Alja Oblak et al. Clinical & Developmental Immunology
- Telomerase Peptide Vaccination Combined with Temozolomide: A Clinical Trial in Stage IV Melanoma Patients
- (2011) J. A. Kyte et al. CLINICAL CANCER RESEARCH
- Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
- (2011) P. F. Brunsvig et al. CLINICAL CANCER RESEARCH
- Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies
- (2011) R. Vermeij et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase-specific GV1001 peptide vaccination fails to induce objective tumor response in patients with cutaneous T cell lymphoma
- (2011) Christoph Schlapbach et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Edward Jenner and the Small Pox Vaccine
- (2011) Kendall A. Smith Frontiers in Immunology
- Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma
- (2010) A. P. Rapoport et al. BLOOD
- Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation
- (2010) K. Birkholz et al. BLOOD
- LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
- (2010) R Matsuda et al. BRITISH JOURNAL OF CANCER
- Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
- (2010) Redas Trepiakas et al. CYTOTHERAPY
- Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos
- (2010) Ilio Vitale et al. EMBO JOURNAL
- Expression of aberrantly glycosylated Mucin-1 in ovarian cancer
- (2010) Catharina H M J Van Elssen et al. HISTOPATHOLOGY
- MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
- (2010) Elke Schultz-Thater et al. INTERNATIONAL JOURNAL OF CANCER
- Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity
- (2010) T. Tsuji et al. JOURNAL OF IMMUNOLOGY
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lack of specific -retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
- (2009) W. R. Burns et al. BLOOD
- Cancer vaccination with telomerase peptide GV1001
- (2009) Jon Amund Kyte EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Topical resiquimod: a promising adjuvant for vaccine development?
- (2009) Manoli Igartua et al. Expert Review of Vaccines
- New perspectives in cancer immunotherapy and immunomonitoring
- (2009) Viktor Umansky et al. Future Oncology
- Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs
- (2009) Mark M Aloysius et al. Journal of Translational Medicine
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Immune Responses in Patients with Metastatic Renal Cell Carcinoma Treated with Dendritic Cells Pulsed with Tumor Lysate
- (2009) A. Soleimani et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Carcinomas of an unknown primary site: a curable disease?
- (2008) A. Levy et al. ANNALS OF ONCOLOGY
- IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder
- (2008) L. Sitnikova et al. CLINICAL CANCER RESEARCH
- Phase I Immunotherapeutic Trial with Long Peptides Spanning the E6 and E7 Sequences of High-Risk Human Papillomavirus 16 in End-Stage Cervical Cancer Patients Shows Low Toxicity and Robust Immunogenicity
- (2008) G. G. Kenter et al. CLINICAL CANCER RESEARCH
- Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding
- (2008) Sjoerd H van der Burg Expert Review of Vaccines
- Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma
- (2008) Annika Berntsen et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search